SABIC Innovative Plastics Showcases Industry-Driven Customer Product Policy and Innovative New Bio-Assessed Materials at MD&M West

Published Jan 13, 2010

PITTSFIELD, Mass. — Jan. 13, 2010 — SABIC Innovative Plastics today announced it will exhibit at MD&M West in Anaheim, Calif., Feb. 9 - 11, at booth 1783, showcasing medical devices that have capitalized on the company’s proactive healthcare product policy which includes more than 50 medical-grade materials. Among other benefits, the policy provides pre-assessment of biocompatibility for SABIC Innovative Plastics’ materials to improve regulatory compliance. The impressive product portfolio continues to expand to give healthcare OEMs and designers greater choices. For example, at MD&M West the company will introduce three new bio-assessed, clear, inherently antistatic LNP* Stat-Loy* specialty compounds that will improve the efficiency of pharmaceutical inhalation devices. SABIC Innovative Plastics offers the medical device industry the broadest product portfolio, the highest standards of quality and unmatched innovation.